Resolutions at the Extraordinary General Meeting in Medivir on 26 January 2018
The Extraordinary General Meeting in Medivir Aktiebolag (publ) (“Medivir”) on 26 January 2018 resolved, among other things, on the following; The meeting resolved to authorize the board, for the period up to the annual general meeting 2018, to resolve to issue new shares of series B with deviation from the shareholders’ pre-emptive rights. The total number of shares that may be issued under the authorization shall total not more than 20 percent of the number of shares of series B issued as per the date of the meeting. The meeting further resolved on an additional issue authorization